263 filings
8-K
BIXT
Bioxytran, Inc
9 May 24
Changes in Registrant's Certifying Accountant
4:43pm
10-Q/A
2024 Q1
BIXT
Bioxytran, Inc
Quarterly report (amended)
22 Apr 24
3:39pm
10-Q
2024 Q1
BIXT
Bioxytran, Inc
Quarterly report
19 Apr 24
4:50pm
8-K
BIXT
Bioxytran, Inc
19 Apr 24
Material Modifications to Rights of Security Holders
4:26pm
10-K
2023 FY
BIXT
Bioxytran, Inc
Annual report
22 Mar 24
5:17pm
424B4
rp60dl 97wtci0k
2 Oct 23
Prospectus supplement with pricing info
11:36am
EFFECT
98fpb vsmzbywinf85
2 Oct 23
Notice of effectiveness
12:15am
CORRESP
5kgw5ktcspc xm
28 Sep 23
Correspondence with SEC
12:00am
UPLOAD
suumblh
26 Sep 23
Letter from SEC
12:00am
CORRESP
g5vfazjy
20 Sep 23
Correspondence with SEC
12:00am
8-K
pvk kjm6pwtz1
24 Aug 23
Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials
9:15am
EFFECT
vp9slc9hmfdwy5q8p9yy
15 Aug 23
Notice of effectiveness
12:15am
424B4
6pp0n02g01jypu wei17
14 Aug 23
Prospectus supplement with pricing info
8:07pm
CORRESP
oevr15pl5xg6suxdiz1
10 Aug 23
Correspondence with SEC
12:00am